<DOC>
	<DOCNO>NCT01776489</DOCNO>
	<brief_summary>Food allergy represent increase health concern industrialize country especially affect pediatric patient . In population adverse reaction food compound lead anaphylactic reaction . Despite substantial research effort , clinical marker predict disease severity symptom miss date . Recent study reveal sphingolipids , especially sphingosine-1-phosphate ( S1P ) , play essential role allergy . It report asthmatic patient higher S1P level bronchiallavage fluid allergen challenge . First experimental study reveal correlation S1P outcome anaphylaxis . Furthermore , show recent mouse study S1P homeostasis pivotal food allergy induction effector cell response . Therefore , aim present pilot project evaluate whether S1P serum titer alter food allergic child S1P level correlate outcome anaphylaxis double blind placebo control food challenge ( DBPCFCs ) .</brief_summary>
	<brief_title>Evaluation Sphingolipid Metabolite S1P Novel Biomarker Food Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Anaphylaxis</mesh_term>
	<criteria>Patients 117 year report suffer food allergic reaction subject DBPCFC open provocation Patients diagnose elevated allergen specific IgE and/or positive skin prick test Willingness participate study Refusal participate study NonIgEmediated food allergy</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Food allergy</keyword>
	<keyword>Sphingosine-1-phosphate</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Double-blind placebo-controlled food challenge</keyword>
	<keyword>Anaphylaxis</keyword>
</DOC>